Anaerobranca Details: NCBI 42447, gram-negative or unknown [genus]

| Anaerobranca| Anaerobranca Engle et al. 1995

1. Gut microbiota composition: Anaerobranca bacteria are part of the complex ecosystem of the gut microbiota, where they interact with other microorganisms and influence overall gut health. The gut microbiota plays important roles in digestion, nutrient metabolism, immune function, and protection against pathogens.

2. Fermentation and SCFA production: Like other members of the Lachnospiraceae family, Anaerobranca bacteria are capable of fermenting dietary fibers and complex carbohydrates in the colon. During fermentation, they produce short-chain fatty acids (SCFAs) such as acetate, propionate, and butyrate. SCFAs have various health benefits, including serving as an energy source for colonocytes, regulating immune responses, and maintaining gut barrier function.

3. Metabolic health: The production of SCFAs by Anaerobranca bacteria and other gut microbes influences host metabolism, energy balance, and glucose homeostasis. SCFAs, particularly butyrate, have been associated with improvements in metabolic health, including enhanced insulin sensitivity, reduced inflammation, and protection against obesity and metabolic syndrome.

4. Immune modulation: Anaerobranca bacteria and their metabolic products may interact with the host immune system and contribute to immune modulation in the gut mucosa. SCFAs produced during fermentation have immunomodulatory effects and can influence the development and function of immune cells such as regulatory T cells (Tregs) and dendritic cells, which play important roles in maintaining immune tolerance and inflammation control.

5. Disease associations: While specific information about the disease associations of Anaerobranca species is limited, alterations in the abundance or composition of Lachnospiraceae bacteria, including Anaerobranca, have been observed in various gastrointestinal disorders such as inflammatory bowel diseases (IBD), irritable bowel syndrome (IBS), and colorectal cancer. Changes in the gut microbiota composition may contribute to disease pathogenesis or serve as markers of disease activity.

A lot more information is available when you are logged in and raise the display level

Other Sources for more information:

• Immune Epitope Database
• The NCBI taxonomy database
• UniProt
• Immune Epitope Taxonomy Database (IEDB)
• AI Engines For more Details: Perplexity  Kagi Labs  You 

More Information

Statistics

NCBI

Data Punk

End Products Produced

Lab Reporting

Different labs use different software to read the sample. See this post for more details.
One lab may say you have none, another may say you have a lot! - This may be solely due to the software they are using to estimate.
We deem lab specific values using values from the KM method for each specific lab to be the most reliable.

Desired Levels Suggestions for Anaerobranca

• Frequency - how often do samples show this bacteria
• UD - An alternative statistical algorithm (which factors in the frequency)
• Kaltoft-Moldrup Heuristic Using uploaded data
• Lab Low and High are calculated using the formula that most labs use: Mean - 2 Standard Deviation to Mean + 2 Standard Deviation

These are values that are computed from lab specific samples (Patent Pending)

Lab	Frequency	UD-Low	UD-High	KM Low	KM High	Lab Low	Lab High	Mean	Median	Standard Deviation	Box Plot Low	Box Plot High	KM Percentile Low	KM Percentile High
Other Labs	0.53			13	12700	0	14441	4518.8	2760	5062.5	13	12700	7.1 %ile	85.7 %ile
biomesight	73.93	0	580	20	3120	0	7687	1644.8	160	3082.9	0	3900	9.6 %ile	91 %ile
thryve	42.24	0	31	18	1603	0	5079	1005.3	141	2078.4	0	1865	8 %ile	92 %ile

External Reference Ranges for Anaerobranca

Anaerobranca (NCBI 42447) per million

Source of Ranges	Low Boundary	High Boundary	Low Boundary %age	High Boundary %age

Statistic by Lab Source for Anaerobranca

These desired values are reported from the lab reports

Lab	Frequency Seen	Average	Standard Deviation	Sample Count	Lab Samples
BiomeSight	78.798 %	0.164 %	0.319 %	2334.0	2962
BiomeSightRdp	19.355 %	0.026 %	0.055 %	6.0	31
custom	4.918 %	1.061 %	0.363 %	3.0	61
Medivere	100 %	0.299 %	0.405 %	7.0	7
Thryve	41.151 %	0.106 %	0.238 %	572.0	1390

To see medical conditions associated you may be logged in

And display level must be raised above public.

I would like to know what can change the quality that I have

• If I want to know that a substance also changes, then I just click on it
• If I want to know which study this information comes from, then I just clink in increases or decreases

Data Contradictions — Limits of Certainity

To get the list of studies, you must be logged in and raise your display level.

🧙? Search Hints:

General Substance	Specific Substance	Effect
Sugar and similar	saccharin	1 Studies recorded. The consensus is Increases📓, Click for details.

---